In a nation where thousands of lives hang in the balance awaiting organ transplants, the U.S. system has long been plagued by systemic failures that have eroded public confidence. Reports of operational flaws, lack of accountability, and even shocking practices—such as initiating organ donation
In the complex world of oncology, multiple myeloma (MM) stands as a formidable challenge, affecting thousands across Europe with its intricate disease mechanisms and diverse patient needs. As the second most common blood cancer after non-Hodgkin lymphoma, MM impacts around 46,000 new individuals
In the complex aftermath of the Supreme Court's 2022 Dobbs v. Jackson Women's Health Organization ruling, which dismantled nationwide abortion rights, a fierce struggle over reproductive healthcare has erupted across state lines in the United States. Republican state attorneys general (AGs) are
What if the erratic rhythm of millions of hearts could be decoded not by a stethoscope, but by the raw power of supercomputers? Atrial fibrillation (AF), the most common type of irregular heartbeat, silently threatens lives worldwide, often leading to devastating strokes. This condition,
Imagine a world where a cancer diagnosis no longer carries the weight of uncertainty, where treatments are tailored to the unique makeup of each patient, and where technology detects the disease before symptoms even appear. This vision is rapidly becoming reality as oncology undergoes a profound
Could a routine mammogram hold more information than meets the eye? With the advent of artificial intelligence (AI), the potential to transform mammogram analysis into a tool for accurately predicting breast cancer risk is now a tangible reality. This game-changing development has emerged as a
The convergence of artificial intelligence and robotics promises significant advances in modern medicine, a topic recently underscored by the successful patient enrollment in the CANSCAN clinical trial. Spearheaded by Vexev, a prominent Australian medical device company, and U.S. Renal Care, this
Schizophrenia and severe mental illnesses present daunting challenges for the medical community, often leading to a fragmented understanding of their neurological underpinnings. This dilemma has inspired significant research efforts, one of the most revolutionary being the Living Brain Project
Antidepressant medications have been a cornerstone of mental health treatment for years, yet for some patients, they come with a significant drawback: unexpected side effects. Recent research led by the University of Tartu Institute of Genomics sheds light on this issue through an in-depth study of
The cancer treatment market is witnessing monumental shifts as leading innovations pave a new path, notably in the fight against mantle cell lymphoma (MCL). With Imbruvica (ibrutinib) being sanctioned by the European Commission as a frontline treatment, a significant transformation in cancer
